Fresh Recalls

FDAClass III · Drug · Recall D-0511-2026 · Recalled May 13, 2026

busPIRone Hydrochloride Tablets recall — Unichem Pharmaceuticals USA Inc.

Agency report date: May 13, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
busPIRone Hydrochloride Tablets
Company / brand
Unichem Pharmaceuticals USA
Lot / serial / date codes
Lot: ZBUL25001, Exp 12/31/2027
Distribution
USA Nationwide
Agency product description and boundaries

busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by Unichem Laboratories LTD., Ind, Area, Meerut Road, Ghazibad - 201 003, India Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-244-05.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Subpotent drug

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: busPIRone Hydrochloride Tablets recall status

3. Open the official notice or contact

Official recall ID
D-0511-2026
Brand
All Unichem Pharmaceuticals USA recalls
Classification
Class III
Units affected
10,875 Bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
East Brunswick, NJ, United States
Firm address
1 Tower Center Blvd Ste 2200, 08816-1145

Identifying details (verbatim from the notice)

Product codes / lots
Lot: ZBUL25001, Exp 12/31/2027
Distribution
USA Nationwide
Firm notified the public via
Letter
FDA event ID
98728
Recall initiated
April 13, 2026
FDA classified
May 1, 2026
FDA report date
May 13, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved August 11, 2026 at 6:00 PM UTC.

Report a data error on this page